Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lantheus Holdings, Inc.LNTH · Entity 690 | Chief Medical Officer | March 04, 2021 | March 08, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lantheus Holdings, Inc.
Report date March 04, 2021 · Filed March 08, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,130 |
Reported balance
After 2021-03-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-03-04 · Sale · Disposed 4,027 · Balance 25,130 F1: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2: Includes 157 shares acquired under the LNTH employee stock purchase plan on September 11, 2020. |
| Common StockSEC Table I · non-derivative | Direct | 58,950 |
Reported balance
After 2021-03-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2021-03-04 · Grant · Acquired 33,820 · Balance 58,950 |
Filing footnotes · ownership attribution and instrument terms
F1: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
F2: Includes 157 shares acquired under the LNTH employee stock purchase plan on September 11, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2021 Filed Mar 8, 2021 20:40 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | GrantCommon Stock | 33,820 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-010471 · doc4.xml · nonDerivative · entry 2 Molnar Istvan · CIK 0001799321 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,950 Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 20:40 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | SaleCommon Stock | 4,027 | $18.40 | $74,096.80 |
DisclosureSEC source: 0000899243-21-010471 · doc4.xml · nonDerivative · entry 1 Molnar Istvan · CIK 0001799321 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,130 F1 · kind: The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4. F2 · balance_after: Includes 157 shares acquired under the LNTH employee stock purchase plan on September 11, 2020. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 16:30 UTC | Lantheus Holdings, Inc. LNTH · Entity 690 | GrantCommon Stock | 29,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007195 · doc4.xml · nonDerivative · entry 1 Molnar Istvan · CIK 0001799321 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.